Hyperglycemia, dyslipidemia, oxidative stress, as well as such related medical conditions as hypertension, androgen-deficient states, unhealthy lifestyle (absence of physical activity, obesity and smoking) are risk factors for the development of both endothelial dysfunction (EnD) and erectile dysfunction (ED) in patients with type 2 diabetes mellitus. Therefore, the aim of our study is to reveal the role of decompensation of the disease and the duration of diabetes mellitus and age-related androgen deficiency (ARAD) in the development of this pathology. The study involved 261 patients with diabetes mellitus living in Azerbaijan at the age from 30 to 60 years and having a history of diabetes mellitus for the period from 6 months to 30 years. International Index of Erectile Function scale was applied to evaluate erectile function in patients. For the diagnosis of endothelial dysfunction we used different routine studies (anamnesis, general medical examination, clinical, biochemical and hormonal tests) as well as special studiespharmaco-doppler sonography, assessment of peak systolic velocity, end-diastolic velocity, and modified method of examination by Mazo E.B. et al. The study revealed correlation between the index of erectile function and the level of glycated hemoglobin, and increasing duration of the disease. Also we have found that prolonged hyperglycemia in conjunction with hypoglycemia episodes leads to depression and sexual disadaptation. We offer to evaluate these facts as risk factors on a par with age factors. Results of the study suggest that long-term decompensation of diabetes mellitus (HbA Ic > 6.5%), and an increase in the duration of diabetes mellitus increase the risk of endothelial dysfunction by 51.9%. Arteriogenic erectile dysfunction is observed against the background of the endothelial dysfunction. All signs of ARAD were revealed in 43.7% of men with type 2 diabetes mellitus enrolled in the study. The presence of ≥ ≥ ≥ ≥ ≥ 3 risk factors for cardiovascular disease in patients with type 2 diabetes mellitus increases the risk of erectile dysfunction by 83.9%.
In patients with type 2 diabetes mellitus (T2DM) decompensation of diabetes (HbA Ic >6.5) leads to the development of endothelial dysfunction (EnD), while the presence of vascular disease leads to diabetic micro-and macrovasculopathies 1 . In these patients hyperglycemia, dyslipidemia, hypertension, obesity, sedentary lifestyle, and smoking play a significant role in the development of EnD. These are also risk factors for the development of cardiovascular disease (CVD) 2, 3 . Developing of oxidative stress that is associated with decompensated diabetes mellitus, decreased activity of endothelial NO-synthase deficiency of androgens and depression play an important role in the development of EnD and erectile dysfunction (ED) 4, 5 . EnD results in the broken vasoconstrictor/vasodilator balance, reduced production of NO, which is the main mediator providing relaxation of smooth muscle cells of the arteries and trabecules with subsequent increase in the inflow of arterial blood and the development of penile erection 6, 7 . Clinical studies have demonstrated that there is a causal relationship between T2DM and low testosterone levels [8] . On the other hand, an addition of androgen-deficient state to T2DM has a negative predictive value 9 . Consequently, the presence of androgen-deficient state, as well as the history and the course of diabetes mellitus are major risk factors in the development of ED.
Aim of the study
To reveal the role and limitations of diabetes mellitus decompensation, and androgendeficient state on the development of ED in T2DM patients.
Materials and methods of the study
The study involved 261 male T2DM patients living in Sheki-Zagatalsky, and BalakenGabalinsky districts of Azerbaijan. The age of the patients was from 30 to 60 years (51.7 ± 8.5). The duration of diabetes mellitus was from 6 months to 30 years (17.4 ± 7.5). The study used individual medical records proposed by the World Health Organization (WHO). International Index of Erectile Function (IIEF) scale was used to evaluate erectile function in patients. According to the IIEF scale, 22-25 points were accepted as the normal range, 17-21 points -mild, 12-16 points -moderately mild, 8-11 -moderate, and 5-7 points -severe degree of the disorder 10, 11 . Hospital scale was used in order to assess the level of anxiety and depression 12 . Androgen-deficient condition or age-related androgen deficiency (ARAD) were diagnosed in the presence of the following signs listed below: a) clinical symptoms of hypogonadism, b) 37 points on the AMS questionnaire, c) total serum testosterone <12 nmol/L and/ or free testosterone level <0.225 nmol/L)
The study of androgen status includes the assessment of clinical androgen deficiency using the standard international AMS questionnaire (Aging Males' Symptoms). This questionnaire consists of 17 questions with the answers by 5-point scale, which allow to reveal sexual, psychological and somatic disorders in patients 13, 14 .
Routine tests were applied for the diagnosis of ED (anamnesis, general medical examination, clinical and biochemical studies) as well as special studies: pharmaco-doppler sonography, assessment of peak systolic velocity (PSV), end-diastolic velocity (EDV) of the blood flow. Determination of serum total testosterone as well as sex hormone-binding globulin (SHBG) was performed by radioimmunoassay method with strategy electronic sr 300 (Germany) analyzer using reagents of the company Beckman Coulter (USA). Blood sample withdrawn in 8-10 a.m. was used for the analysis.
The level of free testosterone was determined using an electronic calculatorconverter, developed by T. Fiers and J.M. Kaufman (available online at http://issam.ch/ freetesto.htm). Consultation of urologist, ophthalmologist, psychiatrist were applied if appropriate. The level of glycated hemoglobin was measured in patients with diabetes mellitus in order to identify the state of decompensation. Vibration, temperature and tactile sensitivity were assessed in order to detect diabetic neuropathy. Modified method of examination by Mazo E.B. et al. was used in all the patients at the beginning and at the end of the study to assess an endothelial function of cavernous arteries 15 . The method consisted of the following: the diameter of the cavernous arteries is assessed by ultrasonography (US); then the pressure in a. brachialis is determined; then the cuff is placed at the base of the genitals and the air is forced in the cuff with the pressure bigger than the systolic pressure of the patient by 10 mmHg. The compression is preserved for 5 minutes. The lack of blood flow in the distal part of the cavernous artery is assessed by ultrasonography. After 5 minutes the cuff is removed. The diameter of distal parts of the cavernous arteries in the cuff area is determined by ultrasonography. The percentage of the increase in cavernous artery diameter (PICAD) is used to assess endothelial function of cavernous arteries:
where D 1 is an average assessment of the decompression diameter of both cavernous arteries; D 2 is an average assessment of postcompression diameter of both cavernous arteries.
If PICAD is less than 50%, this indicates dysfunction of the cavernous arteries
To determine endothelial dysfunction, blood pressure in a. brachialis is determined first of all. Then the air is inflated in the cuff with the pressure higher by 50 mmHg. The compression is preserved for 5 minutes. Pre-and postcompression change in the diameter of the artery is determined in %. If the increase is less than 15%, it is regarded as endothelial dysfunction.
Doppler sonography of cavernous arteries and a. Brachialis was carried out on the "Medison X-8" apparatus with LA 523 10-5 line probe.
Evaluation Psychogenic ED was revealed in 68 (26.1%) patients, arteriogenic ED was revealed in 148 (56.7%) patients, vein occlusive ED was revealed in 25 (9.6%) patients, and mixed vasculogenic ED -in 20 patients. As a result of the studies of endothelial dysfunction and a.Brachialis, and cavernous arteries, we found that patients with arteriogenic ED occur much more frequently than patients with ED of other genesis. In 48 patients suffering from arteriogenic ED and percentage assessment of postcompressive dilation of a.Brachialis below 15% the PICAD index was 28.1±1.3. In other words, it was less than 50% ( Table 1) . Signs of ejaculation and diabetic polyneuropathy were revealed in patients with mixed vasculogenic ED on the background of autonomous diabetic neuropathy.
Monitoring of EnD and ED prevalence in the range of 3 years of age was performed, given that cardiovascular disease is a risk factor. For this purpose, patients were divided into three age groups: 30-39, 40-49, 50-59 years ( Table 2 ). The prevalence of EnD and the ED at the age of 0-39 is 2-3 times less as compared with other age groups.
In 219 (83.9%) of 261 T2DM patients the value of IIEF was below normal. These patients were identified with erectile dysfunction of varying degrees. From 219 patients with erectile dysfunction, 64 (29.2%) were diagnosed with severe form, 35 (15.9%) with mild form, and 120 (54.8%) were diagnosed with moderate form of ED. In 55 patients with moderate ED form (25.1%) it was classified as moderately mild ED, and in 65 (29.7%) patients -as the moderate degree of ED. With the increase in the levels of glycated hemoglobin, we found a correction with increasing cases of severe ED. The results are shown in Table 3 . Despite the fact that cases of ED are present both in compensated and decompensated diabetes mellitus, the incidence of the severe forms increases in case of severe decompensation of diabetes. These are vasculogenic and especially arteriogenic ED form to be the most common in these patients. ED of varying degree was revealed in 94 (77.7%) of 121 T2DM patients with the duration of the disease of <5 years, in 67 (83.6%) of 73 patients with the duration of the disease of 5-10 years, and in 61 (95.5%) of 64 patients with the duration of the disease of more than 10 years. The number of patients with a short duration of the disease is greater, while the prevalence of ED cases in this group is less than that in the other groups (Figure 1) . ED of varying degree was revealed in 94 (77.7%) of 121 T2DM patients with the duration of the disease of <5 years, in 67 (83.6%) of 73 patients with the duration of the disease of 5-10 years, and in 61 (95.5%) of 64 patients with the duration of the disease of more than 10 years. The number of patients with a short duration of the disease is greater, while the prevalence of ED cases in this group is less than that in the other groups (Figure 1) .
The prevalence of hypogonadism was analyzed in three age ranges in men with T2DM. For this purpose patients were divided into three 12.5 ± 4.4% 10.7 ± 4.1% 33.9 ± 6.3% 42.9 ± 6.6% (Table 5) . Obviously, the prevalence of hypogonadism increased in T2DM patients, as well in the general population of men with age. Thus, if only 17% men in the age of 30-39 years had hypogonadism, its prevalence was 3-fold more common in men in the age of 40-49 years. This has a reliable significance compared to the age group of 30-39 years. This trend continues in the older age.
In general, ED of varying degree was detected in 84% (n = 219) of T2DM men. Erectile function was normal only in 16% (n = 42) of men. The mean total score according to IIEF in .3% ** ** P <0.01, *** P <0.001 -significance of differences in the frequency of various degrees of erectile dysfunction in T2DM patients with hypogonadism and without it. the group were in the range of 16.8±0.6. The mean total score according to IIEF in patients with hypogonadism and T2DM was equal to 14.2±0.5 points, while in the group without hypogonadism it was equal to 19.0 ± 0.9 points. The difference between the two groups is statistically significant (Figure 2 ). Mild-moderate (62.6%) and moderate (20.2%) ED were mainly detected in the group of T2DM men with hypogonadism, while the frequency of mild and severe forms was less than 15% (Table 6 ). Clinical picture is somewhat different in the group of patients without hypogonadism. Patients generally have a mild form of ED (47.3%). All other violations are detected much less than in 25% of cases.
DISCUSSION
The results obtained in the study are consistent with the literature data. McVary K.T. showed that there is correlation between the increase in the duration of diabetes, as well as the increased levels of glycated hemoglobin and erectile dysfunction 16 . Kurbatov D.T. et al. note that violation of erectile function in T2DM patients occurs 3 times more often than in the general population and the risk of affection of the small vessels of the corpora cavernosa and nerve terminal departments increases 5 . Romeo 0.K. et al. showed that in case of diabetes mellitus decompensation, cases of depression were much more common in comparison with the general population of T2DM patients. The author also noted their role in the development of erectile dysfunction 17 . All signs of ARAD were revealed in 43.7% of men with type 2 diabetes mellitus enrolled in the current study. These findings are consistent with the other studies. According to professor Vertkin A.L., ARAD is diagnosed in every second male T2DM patient 18 . The group of British scientists also demonstrated that low testosterone levels were detected in 42% of T2DM patients having risk factors 16 . We also studied the ED among patients with hypogonadism, since the presence of two violations adversely affects not only the quality of life, but also the life expectancy of men being in the reproductive age. On the other hand, endocrine disorder (including T2DM) and androgen deficiency as well as the age can cause ED 19 . According to the recommendations of the International Society for Sexual Disorders, the European Society of Urology and the American Association for Sexual Medicine, it is necessary to determine the level of testosterone in the blood in patients with erectile dysfunction and/or loss of libido (class 2a recommendation, level A of evidence) 13 . Our results show that ED is detected in all patients with hypogonadism, whereas ED is detected in 78% of cases in those with normal levels of testosterone. On the other hand, the degree of erectile dysfunction increases in case of hypogonadism. It is obvious that the presence of decompensation of T2DM increases the likelihood of ED 20 . On the other hand, the presence of androgen-deficient state also contributes to the development of ED. Given the complexity and multifactorial development of erectile dysfunction in T2DM patients, some authors propose to allocate it as a separate pathogenic form 21 . Thus, the results of this study confirmed the regularity of the inverse correlation between age and testosterone levels. Age and the presence T2DM are among the most powerful factors contributing to the increased incidence of androgen deficiency states and the development of ED. However, the presence of several risk factors, including duration of decompensation and the duration of T2DM can accelerate this process. The study noted correlation between the index of erectile function and the level of glycated hemoglobin, as well as increased duration of the disease. The presence of e"3 CVD risk factors increases the risk of erectile dysfunction.
CONCLUSIONS

1.
Long-term T2DM decompensation (HbA Ic >6.5%), an increase in the duration of T2DM increase the risk of endothelial dysfunction by 51.9%. Arteriogenic erectile dysfunction is observed against the background of endothelial dysfunction. 2.
All signs of ARAD were revealed in 43.7% of men with type 2 diabetes mellitus enrolled in the study.
3.
The presence of e"3 CVD risk factors in T2DM patients increases the risk of erectile dysfunction by 83.9%. Severe erectile dysfunction forms are present more often in patients being in the state of prolonged decompensation of diabetes mellitus.
